当前位置:首页 - 行情中心 - 丰倍生物(603334) - 财务分析 - 现金流量表

丰倍生物

(603334)

  

流通市值:15.18亿  总市值:68.48亿
流通股本:3181.67万   总股本:1.44亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,351,668,734.433,601,284,107.092,185,678,509.881,525,126,387.58
  收到的税费返还3,860,066.9949,608,588.3738,503,756.8719,445,574.69
  收到其他与经营活动有关的现金2,334,932.616,244,313.792,965,864.022,301,531.27
  经营活动现金流入小计1,357,863,734.033,657,137,009.252,227,148,130.771,546,873,493.54
  购买商品、接受劳务支付的现金1,240,601,086.723,477,884,652.972,208,195,491.831,463,315,722.68
  支付给职工以及为职工支付的现金23,726,482.855,811,870.6241,612,462.3534,292,528.93
  支付的各项税费27,479,618.18117,111,158.5788,646,867.6344,763,788.46
  支付其他与经营活动有关的现金10,705,965.5132,767,717.0721,446,147.6211,980,515.51
  经营活动现金流出小计1,302,513,153.213,683,575,399.232,359,900,969.431,554,352,555.58
  经营活动产生的现金流量净额55,350,580.82-26,438,389.98-132,752,838.66-7,479,062.04
二、投资活动产生的现金流量:
  收回投资收到的现金270,000,000---
  取得投资收益收到的现金747,328.77---
  处置固定资产、无形资产和其他长期资产收回的现金净额-189,248.8598,439.8398,439.83
  收到的其他与投资活动有关的现金279,327.085,741,279.522,122,257.440
  投资活动现金流入小计271,026,655.855,930,528.372,220,697.2798,439.83
  购建固定资产、无形资产和其他长期资产支付的现金10,737,835.9124,357,710.8118,552,431.6714,991,278.83
  投资支付的现金100,000,000300,000,000--
  支付其他与投资活动有关的现金223,9504,840,519.173,770,423.9180,176.97
  投资活动现金流出小计110,961,785.91329,198,229.9822,322,855.5715,171,455.8
  投资活动产生的现金流量净额160,064,869.94-323,267,701.61-20,102,158.3-15,073,015.97
三、筹资活动产生的现金流量:
  吸收投资收到的现金-795,437,746.56--
  取得借款收到的现金20,500,000371,500,000254,500,000193,500,000
  收到其他与筹资活动有关的现金-28,609,172.0417,983,195.0417,983,195.04
  筹资活动现金流入小计20,500,0001,195,546,918.6272,483,195.04211,483,195.04
  偿还债务支付的现金130,400,000436,150,000182,100,000154,250,000
  分配股利、利润或偿付利息支付的现金1,440,574.7510,345,428.66,667,052.14,865,710.79
  支付其他与筹资活动有关的现金-2,842,0002,321,0001,721,000
  筹资活动现金流出小计131,840,574.75449,337,428.6191,088,052.1160,836,710.79
  筹资活动产生的现金流量净额-111,340,574.75746,209,49081,395,142.9450,646,484.25
四、汇率变动对现金及现金等价物的影响-2,392,588.47-103,225.252,291,548.322,093,466.52
五、现金及现金等价物净增加额101,682,287.54396,400,173.16-69,168,305.730,187,872.76
  加:期初现金及现金等价物余额547,191,339.25150,791,166.09150,791,166.09150,791,166.09
  期末现金及现金等价物余额648,873,626.79547,191,339.2581,622,860.39180,979,038.85
补充资料:
  净利润-140,525,241.36-85,063,308.58
  资产减值准备-2,558,367.91-755,770.82
  固定资产和投资性房地产折旧-26,713,277.48-10,947,077.43
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-26,713,277.48-10,947,077.43
  无形资产摊销-1,298,769.43-606,971.99
  长期待摊费用摊销-1,294,823.32-718,752.81
  处置固定资产、无形资产和其他长期资产的损失--32,843.57--729.51
  固定资产报废损失-408,248.96-70,897.98
  公允价值变动损失--423,386.97--225,846.75
  财务费用-7,797,470.14-1,278,611.59
  投资损失--874,291.97--
  递延所得税--3,646,481.6--653,358.14
  其中:递延所得税资产减少--2,797,458.09--503,674.68
    递延所得税负债增加--849,023.51--149,683.46
  存货的减少--283,209,995.35--13,722,336.4
  经营性应收项目的减少--24,855,420.69--107,062,749.42
  经营性应付项目的增加-103,506,289.85-14,547,083.06
  其他--3,575,469.95--4,932,801.66
  现金的期末余额-547,191,339.25-180,979,038.85
  减:现金的期初余额-150,791,166.09-150,791,166.09
  现金及现金等价物的净增加额-396,400,173.16-30,187,872.76
公告日期2026-04-292026-04-102025-11-042025-10-17
审计意见(境内)标准无保留意见标准无保留意见
TOP↑